BioFlag Unveils Cutting-Edge Probiotic Solutions at Vitafoods Europe 2025

BioFlag's Innovation in Probiotics



Introduction
At the recent Vitafoods Europe 2025 event held in Barcelona, BIOFLAG CO., LTD., a leading Chinese probiotic manufacturer, showcased its groundbreaking probiotic solutions based on scientific research. The event attracted significant international media attention, highlighting the pivotal role that probiotics play in health and wellness.

Showcasing Functional Probiotics
BioFlag presented an array of modern products, including clinically studied strains of probiotic bacteria and ready-to-use probiotic blends. These products focus on promoting gut health, regulating the immune system, supporting metabolic health, weight maintenance, oral health, and enhancing emotional well-being. Additionally, BioFlag introduced probiotic formulations that adhere to stringent European and American standards, underscoring the company’s commitment to quality and safety.

Innovative Probiotic Strains
Among the key innovations introduced were various strains that stand out for their unique health benefits:

  • - Bifidobacterium animalis subsp. lactis BL-99: This strain, isolated from the gut microbiota of Chinese mothers and infants, holds 12 patents in China for its efficacy in improving gut health, regulating immune functions, and bone health. Its versatility allows it to be used in infant formulas, yogurts, and dietary supplements.

  • - Lactobacillus paracasei K56: Isolated from healthy Chinese infants, this strain has clinically proven effects in reducing body fat, visceral fat, and waist circumference. It boasts nine Chinese patents and has been the subject of 12 published scientific studies, affirming its health benefits.

  • - Bifidobacterium animalis subsp. lactis CP-9: Extracted from the milk of healthy Chinese mothers, this strain is patented in China as an anti-obesity agent and is used in the treatment or prevention of jaundice.

Comprehensive Probiotic Library
As a representative of the Chinese probiotic industry, BioFlag highlighted the extensive potential of its industrial chain, which includes:
  • - A library of over 3,500 proprietary strains and more than 30 research platforms dedicated to functional probiotics.
  • - Over 130 patents and more than 100 published scientific articles.
  • - International certifications including GMP (Good Manufacturing Practices), FSSC22000, and HALAL.
  • - Versatile production capabilities encompassing powders, tablets, capsules, and various other dosage forms of probiotics.

Future Collaborations
During the expo, BioFlag officially expressed its willingness to collaborate with dozens of companies and institutions from Europe, North America, and other global regions. A company spokesperson stated, “Drawing from nearly two decades of expertise in functional probiotics, we are dedicated to fostering innovation through R&D and smart production to provide top-notch health solutions to our clients worldwide.”

For more detailed information, visit BioFlag's official website.

Conclusion
BioFlag’s participation in Vitafoods Europe 2025 not only reinforces its position as an industry leader but also emphasizes the growing importance of probiotics in promoting health and wellness on a global scale. As the company continues to innovate, the future looks bright for both BioFlag and the probiotic market as a whole.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.